SEC Form 4 · accession 0000950138-19-000125
Elanco Animal Health Inc · ELAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd S. Young
Officer — See Remarks
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | A | 9,817 | $0.00 | A | 18,800 | D | |
| Common StockF2 | Mar 1, 2019 | A | 83 | $0.00 | A | 18,883 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2019, one-third vesting on March 1, 2020, one-third vesting on March 1, 2021, and the remaining vesting on March 1, 2022.
- F2Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2019, vesting on March 1, 2022.
Remarks
Executive Vice President and Chief Financial Officer